Carlos Manrique, MD

Texas Heart Institute Positions

  • Fellow , Cardiovascular Disease Fellowship
  • Fellow, Advanced Heart Failure Fellowship


  • Medical School:

    Pontifica Universidad Javeriana

  • Residency:

    Jacobi Medical Center, Albert Einstein College of Medicine


Manrique, C. R., Tiwari, N. and Plana, J. C. (2017). Cardiac Rhythm Disturbances. In Anti-Cancer Treatments and Cardiotoxicity (95–103). Elsevier.
Manrique, C. R. and Plana, J. C. (2017). Atrial Fibrillation and Stroke in Cancer Patients. In Anti-Cancer Treatments and Cardiotoxicity (131–138). Elsevier.
Manrique, C. R., Park, M., Tiwari, N. et al. (2017). Diagnostic strategies for early recognition of cancer therapeutics-related cardiac dysfunction. Clin Med Insights Cardiol 11, 1179546817697983.
Yu, A. F., Manrique, C., Pun, S. et al. (2016). Cardiac safety of paclitaxel plus trastuzumab and pertuzumab in patients with HER2-positive metastatic breast cancer. Oncologist 21, 418–424.
Wever-Pinzon, O., Romero, J., Kelesidis, I. et al. (2014). Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy: a meta-analysis of prospective trials. J Am Coll Cardiol 63, 1992–2004.
Steingart, R. M., Yadav, N., Manrique, C. et al. (2013). Cancer survivorship: cardiotoxic therapy in the adult cancer patient; cardiac outcomes with recommendations for patient management. Semin Oncol 40, 690–708.
Romero, J., Mejia-Lopez, E., Manrique, C. et al. (2013). Arrhythmogenic right ventricular cardiomyopathy (ARVC/D): a systematic literature review. Clin Med Insights Cardiol 7, 97–114.